Grup de recerca translacional vascular i renal

Publicacions (443)

Cercador de publicacions

Crespo-Masip, M; Pérez-Gómez, A; Guzmán, C; Rayego, S; Doladé, N; García-Carrasco, A; Jover, R; Valdivielso, JM

PTEN Deletion in Adult Mice Induces Hypoinsulinemia With Concomitant Low Glucose Levels.

Frontiers in Endocrinology 13 850214-850214. .

[doi:10.3389/fendo.2022.850214]

Núñez E; Fuster, V; Gómez-Serrano, M; Valdivielso, JM; Fernández-Alvira, JM; Martínez-López, D; Rodríguez, JM; Bonzon-Kulichenko, E; Calvo, E; Alfayate, A; Bermudez-Lopez, M; Escola-Gil, JC; Fernández-Friera, L; Cerro-Pardo, I; Mendiguren, JM; Sánchez-Cabo, F; Sanz, J; Ordovás, JM; Blanco-Colio, LM; García-Ruiz, JM; Ibáñez B; Lara-Pezzi, E; Fernández-Ortiz, A; Martín-Ventura, JL; Vázquez, J

Unbiased plasma proteomics discovery of biomarkers for improved detection of subclinical atherosclerosis.

EBioMedicine 76 103874-103874. .

[doi:10.1016/j.ebiom.2022.103874]

Molina, M; Sorolla, C; Samsó, E; Carcaña, M; Martín, ML; Jatem, E; Pitarch, G; Montero, L; Lauzurica, R; Segarra, A

Quality of Life in Long-Term Renal Transplant Patients: A Controversial Subject

TRANSPLANTATION PROCEEDINGS 54 91-93. .

[doi:10.1016/j.transproceed.2021.11.025]

Molina, M; Sorolla, C; Samsó, E; Carcaña, M; Martín, ML; Jatem, E; Pitarch, G; Montero, L; Lauzurica, R; Segarra, A

Cost of Traveling to Follow-up Appointments at Kidney Transplant Clinics

TRANSPLANTATION PROCEEDINGS 54 94-95. .

[doi:10.1016/j.transproceed.2021.11.005]

Medrano AS; Muijsemberg A; Wimbury D; Martin M; Jatem E; González J; Colás-Campás L; García-Carrasco A; Martínez C; Barratt J

Relationship between IgA1 lectin-binding specificities, mesangial C4d deposits and clinical phenotypes in IgA nephropathy.

NEPHROLOGY DIALYSIS TRANSPLANTATION 37 318-325. .

[doi:10.1093/ndt/gfaa356]

Rayego-Mateos S.; Marquez-Expósito L.; Rodrigues-Diez R.; Sanz A.B.; Guiteras R.; Doladé N.; Rubio-Soto I.; Manonelles A.; Codina S.; Ortiz A.; Cruzado J.M.; Ruiz-Ortega M.; Sola A.

Molecular Mechanisms of Kidney Injury and Repair

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES 23 -. .

[doi:10.3390/ijms23031542]

Mota-Zamorano S; González LM; Robles NR; Valdivielso JM; Cancho B; López-Gómez J; Gervasini G

A Custom Target Next-Generation Sequencing 70-Gene Panel and Replication Study to Identify Genetic Markers of Diabetic Kidney Disease.

Genes 12 -. .

[doi:10.3390/genes12121992]

Purroy F; Sánchez E; Lecube A; Arqué G; Vicente-Pascual M; Mauri-Capdevila G; Torreguitart N; Hernández M; Barbé F; Fernández E; Pamplona R; Farràs C; Mauricio D; Bermúdez-López M

Prevalence and Predictors of Cerebral Microangiopathy Determined by Pulsatility Index in an Asymptomatic Population From the ILERVAS Project.

Frontiers in Neurology 12 785640-785640. .

[doi:10.3389/fneur.2021.785640]

Rojo-López MI; Castelblanco E; Real J; Hernández M; Falguera M; Amigó N; Julve J; Alonso N; Franch-Nadal J; Granado-Casas M; Mauricio D

Advanced Quantitative Lipoprotein Characteristics Do Not Relate to Healthy Dietary Patterns in Adults from a Mediterranean Area.

Nutrients 13 -. .

[doi:10.3390/nu13124369]

Jatem-Escalante, E; Martín-Conde, ML; Gracia-Lavedan, E; Benítez, ID; Gonzalez, J; Colás, L; Garcia-Carrasco, A; Martínez, C; Segarra-Medrano, A

Monitoring anti-PLA2R antibody titres to predict the likelihood of spontaneous remission of membranous nephropathy

Clinical Kidney Journal 14 2556-2562. .

[doi:10.1093/ckj/sfab116]

Bermúdez-López M; Martínez-Alonso M; Castro-Boqué E; Betriu À; Cambray S; Farràs C; Barbé F; Pamplona R; Lecube A; Mauricio D; Purroy F; Valdivielso JM; Fernández E; ILERVAS project collaborators

Subclinical atheromatosis localization and burden in a low-to-moderate cardiovascular risk population: the ILERVAS study.

REVISTA ESPANOLA DE CARDIOLOGIA 74 1042-1053. .

[doi:10.1016/j.rec.2020.09.015]

Castelblanco E; Hernández M; Ortega E; Amigó N; Real J; Granado-Casas M; Miñambres I; Lopez C; Lecube A; Bermúdez-López M; Alonso N; Julve J; Mauricio D

Outstanding improvement of the advanced lipoprotein profile in subjects with new-onset type 1 diabetes mellitus after achieving optimal glycemic control.

DIABETES RESEARCH AND CLINICAL PRACTICE 182 109145-109145. .

[doi:10.1016/j.diabres.2021.109145]